BioFab has extensive expertise and technology for the development of advanced point-of-care testing (POCT) systems. We have a propriety platform which is highly flexible in nature and allows tests to be developed for a wide range of disease conditions in non-clinical settings. Our prototype devices have shown proof-of-principle results demonstrating immunoassay detection of cardiac markers and automated qPCR for Covid-19. We are seeking co-development partners and investment to commercialise our technology. We also provide consultancy services to the healthcare industry, including the development/prototyping of POCT instrumentation and cartridges.
| Website | http://www.biofab.co.uk |
| Employees | 6 (2 on RocketReach) |
| Founded | 2018 |
| Address | Kings Hedges Road, Allia Future Business Centre, Cambridge, England CB4 2HY, GB |
| Technologies | |
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care, Health Diagnostics, Life Science, Medical Device |
| Keywords | Point Of Care Testing, Medical Diagnostics, In Vitro Diagnostics, Ivd, Disease Diagnostics, Testing Technology, Medical Technology, Healthcare Technology, Biotechnology, Medical Devices, Diagnostic Devices, Platform Technology, Flexible Platform, Assay Development, Test Development, Poct Devices, Advanced Diagnostics |
Looking for a particular BIOFAB employee's phone or email?
Rachel Norris is the Executive Consultant of BIOFAB.
2 people are employed at BIOFAB.
BIOFAB is based in Cambridge, England.